Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272233 · ClinicalTrials.gov registry record
Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 22
- Enrollment target
NCT00272233: Completed study, sponsored by Yale University.
NCT00272233 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00272233 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Work requirements for medical trainees result in substantial sleep loss. Sleep loss has been associated with increased levels of certain inflammatory hormones that could have negative impact on blood vessel function. The purpose of this study is to determine the effects of sleep loss on blood hormone levels and blood vessel function in medical trainees.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-06 |
What the finished NCT00272233 record still lists
NCT00272233 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00272233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00272233 about?
NCT00272233 is a clinical study titled "Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents". Work requirements for medical trainees result in substantial sleep loss. Sleep loss has been associated with increased levels of certain inflammatory hormones that could have negative impact on blood vessel function. The purpose of this study is to determine the effects of sleep loss on blood hormon...
What is the current status of trial NCT00272233?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2004-12. Estimated completion is 2005-06.
Who is sponsoring clinical trial NCT00272233?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia